Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 4Head and Neck Neoplasms 2Virus Diseases 1Tumor Virus Infections 1Recurrence 1Pharyngeal Diseases 1Papillomavirus Infections 1Otorhinolaryngologic Neoplasms 1Otorhinolaryngologic Diseases 1Oropharyngeal Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers 1Laryngeal Diseases 1Hypoxia 1DNA Virus Infections 1Carcinoma, Squamous Cell 1Carcinoma 1

Interventions

pembrolizumab 9Cisplatin 9Cetuximab 6Paclitaxel 5Radiotherapy 4Fluorouracil 4zalutumumab 3Nivolumab 3Docetaxel 3Taxes 2Radiotherapy, Intensity-Modulated 2Pemetrexed 2Gefitinib 2Cyclophosphamide 2Carboplatin 2temsirolimus 1sintilimab 1poly ICLC 1osimertinib 1fludarabine phosphate 1fludarabine 1enzalutamide 1durvalumab 1cobimetinib 1atezolizumab 1advexin 1abemaciclib 1Vorinostat 1Sorafenib 1Risk Factors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Neoplasms, Squamous Cell × Nimorazole × Clear all
NCT04124198 2025-12-31

QoLATI

Rigshospitalet, Denmark

Phase NA Active not recruiting
138 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Carcinoma, Squamous Cell, DNA Virus Infections, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Oropharyngeal Neoplasms, Otorhinolaryngologic Diseases, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Tumor Virus Infections, Virus Diseases, Neoplasms, Squamous Cell, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡